Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition Post author: Post published:July 4, 2024 Post category:uncategorized HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. You Might Also Like Mobile van brings advanced lung cancer screening to New Yorkers October 15, 2025 MRI study offers new insights into celiac disease treatment December 8, 2024 Study examines the mechanisms behind long-term consequences of childhood stress March 17, 2025